MX2017015465A - Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol. - Google Patents

Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol.

Info

Publication number
MX2017015465A
MX2017015465A MX2017015465A MX2017015465A MX2017015465A MX 2017015465 A MX2017015465 A MX 2017015465A MX 2017015465 A MX2017015465 A MX 2017015465A MX 2017015465 A MX2017015465 A MX 2017015465A MX 2017015465 A MX2017015465 A MX 2017015465A
Authority
MX
Mexico
Prior art keywords
weight
core
coating layer
meth
relation
Prior art date
Application number
MX2017015465A
Other languages
English (en)
Inventor
Jain Vinay
Lanke Sanjay
GUHA Ashish
M Patel Mitulkumar
Asgarzadeh Firouz
JOSHI Shraddha
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2017015465A publication Critical patent/MX2017015465A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención se refiere a una composición farmacéutica o nutracéutica, que comprende: un núcleo a) que comprende un ingrediente activo y un polímero insoluble en agua, una capa de revestimiento b) por encima del núcleo a) que comprende una sal de un ácido algínico, y una capa de revestimiento c) por encima de la capa de revestimiento b) que comprende un copolímero de (met)acrilato aniónico polimerizado de una mezcla de monómero de (met)acrilato que comprende el 5-75% en peso, con relación al peso total de la mezcla de monómero de (met)acrilato, de monómeros de (met)acrilato con un grupo aniónico, en donde la cantidad del polímero insoluble en agua en el núcleo a) es del 2 al 20% en peso con relación al peso del núcleo a) y la cantidad de la sal de un ácido algínico en la capa de revestimiento b) es del 5 al 85% en peso con relación al peso del núcleo a) y la cantidad del copolímero de (met)acrilato aniónico en la capa de revestimiento c) es del 10 al 75% en peso con relación al peso del núcleo a) y la capa de revestimiento b).
MX2017015465A 2015-06-05 2016-05-23 Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol. MX2017015465A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2843CH2015 2015-06-05
PCT/EP2016/061551 WO2016193034A1 (en) 2015-06-05 2016-05-23 Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol

Publications (1)

Publication Number Publication Date
MX2017015465A true MX2017015465A (es) 2018-03-28

Family

ID=56084021

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017015465A MX2017015465A (es) 2015-06-05 2016-05-23 Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol.

Country Status (14)

Country Link
US (2) US10980751B2 (es)
EP (1) EP3302444B1 (es)
JP (1) JP6824197B2 (es)
KR (1) KR20180015245A (es)
CN (1) CN107708677B (es)
BR (1) BR112017025148A2 (es)
CA (1) CA2986188A1 (es)
ES (1) ES2838816T3 (es)
HK (1) HK1244699A1 (es)
HU (1) HUE052340T2 (es)
IL (1) IL255534A (es)
MX (1) MX2017015465A (es)
SI (1) SI3302444T1 (es)
WO (1) WO2016193034A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019052845A1 (en) 2017-09-14 2019-03-21 Evonik Röhm Gmbh POLYMER AND PHARMACEUTICAL FORM WITH PROLONGED RELEASE PROPERTIES AND RESISTANCE TO THE INFLUENCE OF ETHANOL
MX2020004546A (es) * 2017-11-01 2020-10-05 Edgemont Pharmaceuticals Llc Trust Composiciones farmaceuticas orales de lorazepam resistentes al alcohol.
MX2020009385A (es) 2018-03-09 2020-10-28 Evonik Operations Gmbh Mezcla de polimeros con resistencia a la influencia del etanol.
EP3801462A4 (en) 2018-05-24 2022-03-16 Celanese EVA Performance Polymers LLC IMPLANTABLE DEVICE FOR EXTENDED RELEASE OF A MACROMOLECULAR DRUG COMPOUND
MX2020012459A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
WO2020114714A1 (en) * 2018-12-05 2020-06-11 Evonik Operations Gmbh Process for preparing polymeric particles
US20220087940A1 (en) * 2019-03-11 2022-03-24 Evonik Operations Gmbh Dosage form comprising a polymeric matrix
EP4176874A1 (en) * 2021-11-09 2023-05-10 Evonik Operations GmbH Pharmaceutical or nutraceutical composition with an alcohol resistant single layer coating system

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2135073C3 (de) 1971-07-14 1974-07-11 Roehm Gmbh Überzugsmittel für Arzneiformen
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE10011447A1 (de) 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10013029A1 (de) 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
MXPA02009478A (es) 2001-01-31 2003-03-10 Roehm Gmbh Forma medicinal de multiples particulas que comrpende por lo menos dos formas de bolitas recubiertas de diferente manera.
DE10214002A1 (de) 2002-03-27 2003-10-09 Roehm Gmbh Pharmazeutische Formulierung für den Wirkstoff Budesonid
DE10250543A1 (de) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
DE102004011349A1 (de) 2004-03-05 2005-09-22 Basf Ag Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
DE102004035936A1 (de) 2004-07-23 2006-03-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
EP1799211A1 (en) * 2004-10-05 2007-06-27 Altana Pharma AG Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
DE102005024614A1 (de) 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070104789A1 (en) 2005-11-04 2007-05-10 Donald Spector Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone
DE102007009243A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
DE102007009242A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
SI2230932T1 (sl) 2008-01-10 2017-07-31 Evonik Roehm Gmbh Oplaščeni farmacevtski ali nutracevtski pripravek s povečanim sproščanjem aktivne učinkovine v črevesu
HUE032817T2 (en) * 2009-03-18 2017-11-28 Evonik Roehm Gmbh Regulated release pharmaceutical composition comprising a coating containing neutral vinyl polymers and excipients and resistant to the influence of ethanol
WO2012022498A1 (en) * 2010-08-18 2012-02-23 Evonik Röhm Gmbh Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
KR101973235B1 (ko) 2012-08-27 2019-08-16 에보니크 룀 게엠베하 에탄올의 영향에 대해 지속 방출 특성 및 내성을 갖는 제약 또는 기능식품 조성물
PL2887925T3 (pl) * 2012-08-27 2017-07-31 Evonik Röhm Gmbh Odporna żołądkowo kompozycja farmaceutyczna lub nutraceutyczna z odpornością na wpływ etanolu

Also Published As

Publication number Publication date
CA2986188A1 (en) 2016-12-08
US10980751B2 (en) 2021-04-20
JP2018518478A (ja) 2018-07-12
US20180140556A1 (en) 2018-05-24
HUE052340T2 (hu) 2021-05-28
HK1244699A1 (zh) 2018-08-17
CN107708677B (zh) 2021-07-13
US20210205230A1 (en) 2021-07-08
EP3302444B1 (en) 2020-09-23
SI3302444T1 (sl) 2021-01-29
IL255534A (en) 2018-01-31
CN107708677A (zh) 2018-02-16
WO2016193034A1 (en) 2016-12-08
KR20180015245A (ko) 2018-02-12
JP6824197B2 (ja) 2021-02-03
EP3302444A1 (en) 2018-04-11
BR112017025148A2 (pt) 2018-08-07
ES2838816T3 (es) 2021-07-02

Similar Documents

Publication Publication Date Title
MX2017015465A (es) Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol.
MX2017006858A (es) Composición farmacéutica o nutracéutica con resistencia a la influencia del etanol.
MX347227B (es) Composicion farmaceutica o nutraceutica con liberacion sostenida caracteristica y con resistencia contra la influencia del etanol.
MX355662B (es) Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influencia de etanol.
MX353427B (es) Composicion de recubrimiento adecuada para formas de dosis farmaceuticas o nutraceuticas.
MX353426B (es) Composicion de recubrimiento apropiada para formas de dosificacion farmaceuticas o nutraceuticas.
MX2011009669A (es) Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante un revestimiento compuesto de una mezcla polimérica y excipientes.
MX2015017289A (es) Procedimiento de dispersión de microcapsular que comprende microcápsulas con un núcleo capsular hidrófilo.
MX358196B (es) Composicion farmaceutica o nutraceutica con caracteristica de liberacion sostenida y con resistencia contra la influencia del etanol.
MX2016010843A (es) Composiciones de copolimero de etapa multiple para usarse en recubrimiento final de cuero.
MY176208A (en) Block copolymer and adhesive composition
MY188161A (en) Pressure sensitive adhesive compositions and methods for preparing same
EP2492330A3 (en) Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet
BR112017024508A2 (pt) copolímero solúvel para pelo menos 2% em peso em diesel a 25ºc, pacote aditivo para combustíveis, método de preparação de copolímero, método de preparação de um pacote de aditivos para combustível, e uso de polímero
EA033134B1 (ru) Асфальтовая композиция
MX356579B (es) Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.
WO2013095993A3 (en) Water resistant personal care polymers
NZ736149A (en) Durable anti-fingerprint polymers and coating compositions
BR112017024047A2 (pt) copolímero, pacote aditivo para combustíveis, método de preparação de copolímero, e uso de polímero ou pacote de aditivo
MX2018005415A (es) Composicion formadora de pelicula dental duradera y usos de esta.
BR112016025501A2 (pt) composição de revestimento
WO2015116916A8 (en) Resin-support emulsion polymerization of hydrophobic monomers
BR112018010757A2 (pt) composição.
MX2015010449A (es) Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
MX344482B (es) Adhesivos estructurales, proceso para su preparacion y su aplicacion.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: EVONIK OPERATIONS GMBH

HC Change of company name or juridical status

Owner name: EVONIK OPERATIONS GMBH

Owner name: KONECRANES GLOBAL CORPORATION

FG Grant or registration